Arthur Pharma

Arthur Pharmaceutical Co., Ltd., is founded in March, 2020. An established pharmaceutical company focusing on complex generic drug development and production. Our newly established injection facility comply with FDA cGMP and China GMP requirements. Currently, more than 30 products are under development. Arthur Group LLC, our subsidiary company, is located in New Jersey, with its main business on regulatory filing and US Market distribution. Stage I: Arthur Pharma covers an area of 5600m² for its R&D center, which include four teams, the API department, OSD formulation department, Injection formulation department, and R&D department. Our R&D team are located in Jiaxing, Zhejiang, China. Stage II: Arthur Pharma is currently establishing an injectable facility with an area of 33,000 m². It is planned for the production of different injection products, including the oncology products, pre-fill syringe products, and ordinary injection products. Our oral solid product manufacturing lines are on designing stage.